˜_•¶

2019”N

ŒF–{’nk‚ɂ‚¢‚Ä

Œ´“c³Œö, ûü‹´‹B
ˆã—Ã. 2019; 73(4): 202-205

ŒF–{Œ§Á–h–hÐƒwƒŠ‚Ì“VŒóEŠˆ“®ŽžŠÔ‚É‚æ‚錻ê‹~‹}•âŠ®Šˆ“®‚ÌŒŸ“¢

‹àŽq—B, ŽR“cŽü, “c’†‘ñ“¹, Œ´“c³Œö, –Ø‘º•¶•F, ‚‹´‹B, Š}‰ªrŽu
“ú–{q‹óˆã—Êw‰ïŽGŽ. 2019; 19(3): 21-24

Comparative study on quick sequential organ failure assessment, systemic inflammatory response syndrome and the shock index in prehospital emergency patients: single]site retrospective study

Masahiro Harada, Takeshi Takahashi, Yoshio Haga, Takeshi Nishikawa
Acute Med Surg. 2019; 6: 131-137

2018”N

y‚¹‚ñ–ϐf—Ãup-to-date@Œy‚¢ˆÓŽ¯‚Ì“Ü‚è‚ɐöÝ‚·‚郊ƒXƒN‚Æ‘‰Á‚·‚鍂—î‹~‹}Š³ŽÒ‚ɑΉž‚·‚邽‚߂Ɂz
‚¹‚ñ–Ï‚ð’æ‚·‚钍ˆÓ‚·‚ׂ«‹@˜EöÝŽ¾Š³

‹´–{ ‘, ‹{“à ‘å‰î, ŽR‰º Œšº, “n•Ó Œ’ŽŸ˜Y, ‚‹´ ‹B
¸_‰È‹~‹}. 2018; 21: 15-20

One-hour oral glucose tolerance test plasma glucose at gestational diabetes diagnosis is a common predictor of the need for insulin therapy in pregnancy and postpartum impaired glucose tolerance

Nishikawa T, Ono K, Hashimoto S, Kinoshita H, Watanabe T, Araki H, Otsu K, Sakamoto W, Harada M, Toyonaga T, Kawakami S, Fukuda J, Haga Y, Kukidome D, Takahashi T, Araki E
J Diabetes Investig. 2018; 9(6): 1370-1377

ÐŠQ’´‹}«Šú‚É‚¨‚¯‚鍑—§•a‰@‹@\‰“®ˆã—Ôǂɂæ‚é•a‰@Žx‰‡‚Ì—L—p«

Œ´“c³Œö, ŽR“cŽü, –k“c^ŒÈ, ŸNˆä¹‘å, ‚‹´‹B
ˆã—Ã. 2018; 72(1): 23-26

kÐˆã—Â͓ˑR‚â‚Á‚Ä—ˆ‚é ŒF–{’nk‚ðŒoŒ±‚µ‚Ä

‚‹´‹B
‘啪Œ§—§•a‰@ˆãŠwŽGŽ. 2018; 45: 78-92

Venous Thromboembolism Caused by Spending a Night in a Vehicle After an Earthquake (Night in a Vehicle After the 2016 Kumamoto Earthquake)

Sueta D, Hokimoto S, Hashimoto Y, Sakamoto K, Hosokawa H, Nishigami K, Sato K, Fujisue K, Kojima S, Takahashi T, Hanzawa K, Ogawa H, Tsujita K; Kumamoto Earthquake Thrombosis and Embolism Protection (KEEP) Project Investigators.
Can J Cardiol. 2018;@34(6):@813.e9-813.e10.

2017”N

Predictors Of Inhalation Burn Injury Using Fire Site Information

Kaneko T, Tanaka H, Yamada S, Kitada M, Sakurai T, Harada M, Kimura F, Takahashi T, Kasaoka S
Ann Burns Fire Disasters. 2017; 30(4): 275-277

ŒF–{Œ§Á–h–hÐƒwƒŠ‚ÆŒF–{Œ§ƒhƒNƒ^[ƒwƒŠ‚Ì‹~‹}Œ»êŠˆ“®‚ÉŠÖ‚·‚é”äŠrŒŸ“¢

‹àŽq —B, “c’† ‘ñ“¹, ŽR“c Žü, Œ´“c ³Œö, –Ø‘º •¶•F, ‚‹´ ‹B, Š}‰ª rŽu
“ú–{q‹óˆã—Êw‰ïŽGŽ. 2017; 18(3): 3-7

Predictors of short-term repetition of self-harm among patients admitted to an emergency room following self-harm: A retrospective one-year cohort study

Kawahara YY, Hashimoto S, Harada M, Yamada S, Kitada M, Sakurai T, Takahashi T, et al.
Psychiatry Res. 2017; 258: 421-426.

‰ß—Ê•ž–ò‚©‚çCPA‚Æ‚È‚Á‚½‚ªŽÐ‰ï•œ‹A‚µ‚½ˆê—á

ŽR‰ºŠô‘¾˜Y, ]—ǐ³, Žë–ì˜j•½, ŽR“cŽü, ŸNˆä¹‘å, –k“c^ŒÈ, Œ´“c³Œö, ‹´–{‘, –Ø‘º•¶•F, ‚‹´‹B
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2017; 16(1): 137-140

“ü—’†“M…‚µ‚½10ƒJŒŽ‚̏¬Ž™‚ɑ΂µ‚‹Cˆ³Ž_‘fŽ¡—ÂðŽ{s‚µ‚½1—á

“c‘㔎’, …ã’q”V, Œ´“c³Œö
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2017; 16(1): 147-152

Œ´ˆö•s–¾‚Ì‹}«–ò•¨’†“łɑ΂µ‚āA’PƒŒŒŸ÷ŒðŠ·‚ª—LŒø‚Å‚ ‚Á‚½ˆê—á

’|–{—E‰î, ²“¡•üÆ, ì“à’¼, “c‘㔎’, ]—ǐ³
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2017; 16(1): 153-156

AED‚ÌŽ©“®‰ðÍ‚ŏœ×“®•s—v‚̐f’f‚ð‚µ‚½VT‚̈ê—á

–kìÆ, ²“¡•üÆ, ’|–{—E‰î, V–ؐM—T, “c‘㔎’
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2017; 16(1): 157-160

¶“àèòÃ–¬‚©‚獶”x–å•”ˆÙíŒŒŠÇ‚Ö’†SÃ–¬ƒJƒe[ƒeƒ‹‚ª‘}“ü‚³‚ꂽ1—á

‹àŽq—B, ŽR“cŽü, –k“c^ŒÈ, ŸNˆä¹‘å, Œ´“c³Œö, –Ø‘º•¶•F, Š}‰ªrŽu, ‚‹´‹B
ICU‚ÆCCU. 2017; 41(3): 203-204

ŒF–{Œ§Á–h–hÐƒwƒŠŒ»ê‹~‹}Šˆ—p‚ÉŠÖ‚·‚élŽ@

‹àŽq—B, “c’† ‘ñ“¹, ŽR“c Žü, Œ´“c ³Œö, –Ø‘º •¶•F, ‚‹´ ‹B, Š}‰ª rŽu
“ú–{q‹óˆã—Êw‰ïŽGŽ. 2017; 18(1): 3-8

2016”N

New clinical decision rule to exclude subarachnoid haemorrhage for acute headache: a prospective multicentre observational study

Kimura A, Takahashi T, Harada M, et al.
BMJ Open. 2016; 6: e010999

ˆãŽtŽ––±ì‹Æ•â•ŽÒ‚Ì‹~‹}Šˆ“®ŒŸØ•[‚̍쐬‹Æ–±•â•‚É‚æ‚éˆãŽt‚Ì‹Æ–±ŒyŒ¸‚ɂ‚¢‚Ä

—Ñ“c‚µ‚Ì‚Ô, ‹àŽq•à, —Ñ“c•üŽq, ‘O“cŒb”üŽq, ’†“‡‚݂ËI, •ÐŸº–Î, ]—ǐ³, Žë–ì˜j•½, ŽR“cŽü, ŸNˆä¹‘å, –k“c^ŒÈ, ‹g“c—fŽq, ‹´–{‘, ‹´–{ÍŽq, Œ´“c³Œö, ‘댫ˆê˜Y, ‚‹´‹B
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2016; 15(1): 76-81

‹}«äX‰Š‚É”º‚Á‚½”牺Œ‹ß«Ž‰–b‰óŽ€Ç

•Ä–ž•¶, –q–ìŒöŽ¡, Œ´“c³Œö, et al.
”畆•af—Ã. 2016; 38(1): 45-48

“«‹¹• …Š³ŽÒ‚ÌŽ¡—Âɑ΂·‚é‰ü—ÇŒ^• …”ZkƒVƒXƒeƒ€AKM-CART‚̉ž—p‚ɂ‚¢‚Ä

ì“à’¼, ’|–{—E‰î, ²“¡•üÆ, “c‘㔎’, V–ؐM—T, –kìÆ, X‰i—ǘa, ¼‰º®ô
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2016; 15(1): 39-42

lHŒÄ‹zŠíƒAƒ‰[ƒ€‚ƃi[ƒXƒR[ƒ‹‚Ƃ̘A“®ƒP[ƒuƒ‹‚ÌŽŽì

“c‘㔎’, –kìÆ, V–ؐM—T
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2016; 15(1): 33-38

Ž‘±“IŒŒ‰tò‰»—Ö@‚ÌŽ‘±ŠÉ™Ž®ŒŒ‰tàh‰ßŠí‚Ì‘I‘ð‚ÌŒŸ“¢

²“¡•üÆ, ’|–{—E‰î, ì“à’¼, “c‘㔎’, •x“c³˜Y, ŠŒ´Œ’Œá, â—œˆ», ’†ì‹P­
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2016; 15(1): 125-128

lHŒÄ‹z—Ö@‚É‚¨‚¯‚é‰Á‰·‰ÁŽ¼Ší‚̐«”\‚ÌŒŸØ

–kìÆ, ²“¡•üÆ, ’|–{—E‰î, V–ؐM—T, ì“à’¼, “c‘㔎’, ]èŒö–¾
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2016; 15(1): 47-54

ƒEƒCƒ‹ƒXœ‹Ž—Ö@Ž{sŠ³ŽÒ‚ÌHCV-RNA•Ï‰»‚ɂ‚¢‚Ä

’|–{—E‰î, ²“¡•üÆ, ì“à’¼, “c‘㔎’, ™˜a—m
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ. 2016; 15(1): 50-53

2015”N

2014”N

”sŒŒÇ«”dŽí«ŒŒŠÇ“à‹ÃŒÅ‚É‚¨‚¯‚é—\Œã—\‘ªˆöŽq‚Æ‚µ‚Ä‚Ì protein C Šˆ«‚ÌŒŸ“¢

ŸNˆä¹‘å, ŽR“cŽü, –k“c^ŒÈ, ‹´–{‘, ‹´–{ÍŽq, –Ø‘º•¶•F, Œ´“c³Œö, ‚‹´‹B
“ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 2014; 21(6): 614-622

–ƒáƒ«ƒCƒŒƒEƒX‚ªŠÖ—^‚µ‚½‚ÆŽv‚í‚ꂽL‰»ƒWƒXƒ`ƒOƒ~ƒ“‚É‚æ‚éƒRƒŠƒ“ì“®«ƒNƒŠ[ƒ[‚̈ê—á

ŸNˆä¹‘å, ŽR“cŽü, –k“c^ŒÈ, ‹´–{‘, ‹´–{ÍŽq, –Ø‘º•¶•F, Œ´“c³Œö, ‚‹´‹B
“ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 2014; 21: 635-638

‘¼Ž¾Š³‚ðŠÓ•Ê‚µŽ‰–bÇðÇŒóŒQ‹^‚¢‚Ɛf’f‚µ‚½ˆê—á

Œ´“c³Œö, ]—ǐ³, Žë–ì˜j•½, ŽR“cŽü, ŸNˆä¹‘å, –k“c^ŒÈ, ‹´–{‘, ‹´–{ÍŽq, –Ø‘º•¶•F, ‚‹´‹B
“ú–{—Տ°‹~‹}ˆãŠw‰ïŽGŽ. 2014; 17(6): 800-804

Feasibility study of immediate pharyngeal cooling initiation in cardiac arrest patients after arrival at the emergency room

Takeda Y, HaradaM ,et al
Resuscitation. 2014; 85(12): 1647-1653.

is«‹ØˆÞkÇ‚Ì‚P–UŒŸ—á |is«‹ØˆÞkÇ‚Í lower-motor predominant ALS ‚Ì‚PˆŸŒ^‚Å‚ ‚é|

¬ã’K, •U“N, Œ´“c³Œö, ‚‹´‹B, ‘ºŽRŽõ•F
BRAIN and NERVE. 2014; 66(11): 1405-9

ˆô“ªA“ª‰Š‚ð‡•¹‚µ‚½¬l‚ł̐…“—ÄŠ´õ‚̈ê—á

Œ´“c³Œö, ]—ǐ³, Žë–ì˜j•½, ŽR“cŽü, ŸNˆä¹‘å, –k“c^ŒÈ, –q–ìŒöŽ¡, ‚‹´‹B
“ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 2014; 21(4): 346-9

ŠOŠ³ŽÒ‚É‚¨‚¯‚錌’†ƒvƒƒJƒ‹ƒVƒgƒjƒ“‚Ì‹}«Šú‚̏㏸‚ɂ‚¢‚Ä‚ÌŒŸ“¢

Œ´“c³Œö, ã”VŒ´LŽi, ™“c‹žˆê, ‹e–ì—²–¾, ¬ˆä“y—Yˆê, –Ø‘ºº•v, ‚‹´—§•v, Žáˆä‘’q, ìè’å’j, ‹{‰Á’J–õ‰î, ‹àŽq—B, ŒF’J˜a”ü, ‚ŽR”¹l, ‚‹´‹B
“ú–{‹~‹}ˆãŠw‰ïŽGŽ. 2014; 25(3): 81-92

•½¬26”N“x“ú–{‹~‹}ˆãŠw‰ïÅ—DG‰ÈŠw˜_•¶Ü‚ðŽóÜ‚¢‚½‚µ‚Ü‚µ‚½B‘—§•a‰@‹@\‹~–½‹~‹}ƒZƒ“ƒ^[’·‹¦‹c‰ï\¬Ž{Ý‚̐搶•û‚É‚Í‘å•Ï‚¨¢˜b‚É‚È‚è‚Ü‚µ‚½B
The prevalence of the metabolic syndrome in stroke patients: a prospective multicenter study in Japan

Takahashi T, Harada M, Kikuno T, Ujihara M, Sadamitsu D, Manabe Y, Yasaka M, Takayama H, Kobori S, Araki E
Acute Med Surg. 2014; 1(1): 17-22

2013”N

ŒF–{Œ§‚É‚¨‚¯‚éƒhƒNƒ^[ƒwƒŠƒRƒvƒ^[‚ƏÁ–h–hÐƒwƒŠƒRƒvƒ^[‚Ì‘ŠŒÝ•âŠ®‘̐§‚Ì’†‚ł̏Á–h–hÐƒwƒŠƒRƒvƒ^[‚ð—p‚¢‚½Œ»ê‹~‹}Šˆ“®‚ÌŒ»ó‚Ɖۑè

Œ´“c³Œö, ]—ǐ³, ŽR“cŽü, –k“c^ŒÈ ,ŸNˆä¹‘å, –Ø‘º•¶•F, ‚‹´‹B
“ú–{q‹óˆã—Êw‰ïŽGŽ. 2013; 14(3): 3-9

‡V“x”M’†Ç‚É”º‚¤DIC‚ɑ΂µ‚ăgƒƒ“ƒ{ƒ‚ƒfƒ…ƒŠƒ“ƒAƒ‹ƒtƒ@‚ª‘tŒ÷‚µ‚½2Ç—á

ŸNˆä¹‘å, ŽR“cŽü, –k“c^ŒÈ, ‹´–{‘, Œ´“c³Œö, –Ø‘º•¶•F, ‚‹´‹B
“ú–{‹~‹}ˆãŠw‰ïŽGŽ. 2013; 24(6): 367-73

A Phase II study of polyclonal anti-TNF-a (AZD9773) in Japanese patients with severe sepsis and/or septic shock

Aikawa N, Takahashi T, Fujimi S, Yokoyama T, Yoshihara K, Ikeda T, Sadamitsu D, Momozawa M, Maruyama Y
J Infect Chemother. 2013; 19: 931-940

•ï’š‚É‚æ‚鉺‘åÃ–¬‘¹‚ɑ΂µ‚ÄŽ©ŒÈS”‚ð‰·‘¶‚µ‚½‘ÌŠOzŠÂ‰º‚ɉº‘åÃ–¬C•œp‚ðŽ{s‚µ‚½1Ç—á

¬Ž›ŒúŽu, ‹{è’¼Ž÷, ‘댫ˆê˜Y, ]èŒö–¾, ‰ª–{ŽÀ, ”öèé”V, ‹{¬M—F, –k“c^ŒÈ, Œ´“c³Œö, ‚‹´‹B
“ú–{—Տ°‹~‹}ˆãŠw‰ïŽGŽ. 2013; 16(2): 120-5

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis - The ACCESS Randomized Trial -

Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Aikawa N, et al
JAMA. 2013; 309(11): 1154-1162

f’f‚É“ïa‚µ‚½‹´’†S‘â•ö‰óÇ‚̈ê—á

ŸNˆä¹‘å, ŽR“cŽü, –k“c^ŒÈ, ‹´–{‘, ‹´–{ÍŽq, –Ø‘º•¶•F, Œ´“c³Œö, ‚‹´‹B
“ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 2013; 20: 641-2

Š´õ«DIC‚É‚¨‚¯‚郊ƒRƒ“ƒrƒiƒ“ƒgƒgƒƒ“ƒ{ƒ‚ƒfƒ…ƒŠƒ“’P“Æ“Š—^‚ƃAƒ“ƒ`ƒgƒƒ“ƒrƒ“•¹—p“Š—^‚̗Տ°Œø‰Ê‚Ì”äŠrŒŸ“¢

ŸNˆä¹‘å, ŽR“cŽü, –k“c^ŒÈ, ‹´–{‘, Œ´“c³Œö, –Ø‘º•¶•F, ‚‹´‹B
“ú–{‹~‹}ˆãŠw‰ïŽGŽ. 2013; 24(3): 132-9

Ã’–ò•¨í—pŽÒ‚É‚¨‚¯‚銴õ«S“à–Œ‰Š‚̈ê—á

“c’†–r˜Y, ‰ª–{ŽÀ, ŸNˆä¹‘å, et al.
“ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 2013; 20(1): 29-33

2012”N

‹}«ƒeƒIƒtƒBƒŠƒ“’†“łɑ΂µ‚ÄŒŒ‰t‹z’…—Ö@‚ðŽ{s‚µ‚½1Ç—á

¬Ž›ŒúŽu, ŸNˆä¹‘å, –k“c^ŒÈ, ŽR“cŽü, Œ´“c³Œö, Žë–ì˜j•½, ]—ǐ³, ‚‹´‹B
“ú–{—Տ°‹~‹}ˆãŠw‰ïŽGŽ. 2012; 15(4): 558-61

2011”N

uˆ¢‘hƒ‚ƒfƒ‹vƒ‚ƒoƒCƒ‹ƒeƒŒƒƒfƒBƒVƒ“ƒVƒXƒeƒ€‚ÌŠJ”­ŽÀ—p‰»Œ¤‹†

‚‹´‹B, Œ´“c³Œö, ¼–{”ŽŽu
“ú–{‰“Šuˆã—Êw‰ïŽ. 2011; 7(2): 138-139

lŠÔƒhƒbƒN‚É‚¨‚¯‚錴”­«•›bó‘B‹@”\˜´iÇ‚̃XƒNƒŠ[ƒjƒ“ƒO

“Œ‹Pˆê˜N, Ž™‹ÊÍŽq, –L‰i“NŽŠ, “‡ì–¾Žq, “ˆ“c‚³‚â‚©, ‚‹´‹B, ˆê£N_, ]Šp½, ‹v“c³’¼, ’ß“c•q‹v
“ú–{lŠÔƒhƒbƒNŠw‰ïŽ. 2011; 26: 498-505

2010”N

PTRA‚ª‘tŒ÷‚µ‚½üˆÛ‹Ø«ˆÙŒ`¬‚É‚æ‚étŒŒŠÇ«‚ŒŒˆ³‚Ì‚P—á

‘¾—ÇŽj˜Y@–L‰i“NŽŠ@‹ààV®“¿@‰Ô’J‘Žq@Ž™‹ÊÍŽq@“¡–{˜a‹P@‚‹´‹B@“Œ‹Pˆê˜N
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ 10(1): 74-79, 2010

‘Û‹¤“¯Ž¡Œ±‚Ö‚ÌŽæ‚è‘g‚݂ɂ‚¢‚Ä

—я~ˆê˜Y@–©–{N‘¥@‰œŽR—R‰ÀŽq@Žs‰º—R”ü@‹{–{”ü•ä@³‘ã“ÖŽq@‚‹´‹B
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ 10(1): 58-62, 2010

ŽŸŠúƒ‚ƒoƒCƒ‹EƒeƒŒƒƒfƒBƒVƒ“‚ÌŠJ”­Œ¤‹† -ƒvƒƒgƒ^ƒCƒv‚̍쐬-

‚‹´‹B@Œ´“c³Œö@¼–{”ŽŽu
“ú–{‰“Šuˆã—Êw‰ïŽGŽ 6(2): 197-198, 2010

Timing of the appearance of early hypodense computed tomography signs in patients with middle cerebral artery/internal carotid artery embolism

Takahashi T, Yamada S, Shimizu C, Kitada M, Sakurai T, Hashimoto S, Harada M
JJAAM 21(4): 159-164, 2010

2009”N

œ”ՍœÜ‚É‚æ‚艼«“®–¬áŽ‚ðŒ`¬‚µœ”Õ“à“®–¬Çðp‚ð—v‚µ‚½‚P—á

]“¡O“ñ˜Y@‹´–{‘@Œ´“c³Œö@Ž™‹ÊÍŽq@‹g‰ª–¾Žq@‚‹´‹B
‘—§•a‰@‹@\ŒF–{ˆã—ÃZƒ“ƒ^[ˆãŠwŽGŽ 9(1): 74-78, 2009

Usefulness of Mobile Telemedicine System in Real-Time Transmission of Out-of-Hospital 12-Lead ECGs and Live-Images of Patients on Moving Ambulances

Takahashi T, Harada M, Yokoyama H, Nonogi H
JTTA 5(2): 151-154, 2009

Usefulness of Varying ST changes in transmitted 12-lead electrocardiogram from a moving ambulance with the Mobile Telemedicine System in a patient with acute myocardial infarction

Takahashi T, Harada M, Yokoyama H, Nonogi H
JTTA 5(2): 184-185, 2009

‘—§•a‰@‹@\‚Ì‹~–½‹~‹}ƒZƒ“ƒ^[‚É‚¨‚¯‚é‰@ŠOS”x’âŽ~Š³ŽÒ‚Ö‚Ì Œo”ç“IS”x•â•‘•’uiPCPSjŽg—p—á‚Ì’²¸

‚‹´‹B@Œ´“c³Œö@ã”VŒ´LŽi@¬ò‰ë“T@“àŽR—T”V@‹e–ì—²–¾@–{ŠÔ³l@ŽR–{r˜Y@“¡“c½ˆê˜Y@‚‹´—§•v@ŠÖK—Y@Ž›¼Žm@Î‘qG‹±@’èŒõ‘åŠC@‹{‰Á’J–õ‰î@²”ŒW¬@‚ŽR”¹l@¬–xËŽO@–Ø‘ºº•v
ˆã—à 63(7): 431-435, 2009

Efficacy of vasopressin administration in the resuscitation of out-of-hospital cardiopulmonary arrest patients

Takahashi T, Harada M, Uenohara K, Kikuno T, Honma M, Takahashi T, Ishikura H, Sadamitsu D, Miyagatani K, Yamashita H, Koga Y, Saeki S, Takayama H, Kobori S, Kumura A
IRYO 63(6): 380-385, 2009

2008”N

A patient with a middle cerebral artery embolism and widespread early CT signs who recovered almost completely following superselective thrombolytic therapy

Takahashi T, Takita T, Kozaki Y, Harada M, Kodama S, Yoshioka A, Kobori S
J Jpn Soc Intensive Care Med 15(1): 83-86, 2008

2007”N

•›t‘BŽî“EoŒã‚É“œ”A•aE‚ŒŒˆ³Ç‚ª‰ü‘P‚µ‚½CushingÇŒóŒQ‚Ì1—á

ŽR‘º–¾Žq@´…ç‰ØŽq@‚‹´ˆŸ‹I@•û^‹MŽq@ŽsŒ´‚ä‚©‚è@Ž™‹ÊÍŽq@–L‰i“NŽŠ@‚‹´‹B@¬–xËŽO@“Œ‹Pˆê˜N
NHOŒF–{ˆãŽ 8(1): 67-72, 2007

‰ß•q«”x‘Ÿ‰Š‚Æ‚ÌŠÓ•Ê‚ª–â‘è‚Æ‚È‚Á‚½‹}«DŽ_‹…«”x‰Š

´…ç‰ØŽq@”‹Œ´—˜“ށ@“cKŽçŠg@X¼‰ÃF@‰i–쏁“ñ
NHOŒF–{ˆãŽ 8(1): 58-62, 2007

‹~‹}ŠO—ˆŽófŽž‚Ì’áƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ðŒ_‹@‚ɐf’f‚³‚ꂽ‹U«•›bó‘B‹@”\’ቺÇ‡TbŒ^‚Ì1—á

ŽsŒ´‚ä‚©‚è@Ž™‹ÊÍŽq@‚‹´‹B@¬–xËŽO@“Œ‹Pˆê˜N@‰PˆäŒ’
NHOŒF–{ˆãŽ 7(1): 52-56, 2007

Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: Implication from Japan lipid intervention trial (J-LIT)

The J-LIT Study Group
Atherosclerosis 191: 440-446, 2007

Effect of hypertension and Type 2 diabetes mellitus on the risk of total cardiovascular events in Japanese patients with hypercholesterolemia: Implications from the Japan lipid intervention trial (J-LIT)

The J-LIT Study Group
Atherosclerosis 191: 440-446, 2007

2006”N

Rapidly progressive paraplegia due to Spinal Epidural Abscess: impotance of early diagnosis

Takahashi T, Kozaki Y, Honda S, Ishihara D, Kurisaki R, Harada M, Yoshioka A, Kobori S
Med J NHO Kumamoto MC 5(1): 43-46, 2006

“œ”A•a‹³ˆç“ü‰@ƒNƒŠƒeƒBƒJƒ‹ƒpƒX“dŽq‰»‚Ì•]‰¿

¬–xËŽO@ŽsŒ´‚ä‚©‚è@Ž™‹ÊÍŽq@‚‹´‹B@“Œ‹Pˆê˜N@‹{è‹v‹`
“úˆãƒ}ƒlƒWƒƒ“ƒg‰ïŽ 7(2): 315-319, 2006

¸_”­’B’x‘؏Ǘá‚Ì‹Ù’£«ŒŒ‹C‹¹‚ɑ΂µ—L—p‚Å‚ ‚Á‚½pŒã‹¹oƒhƒŒ[ƒ“–¢—¯’u‹¹o‹¾Žèp

X¼‰ÃF@ŽR‰ºáÁˆê@h“‡—´ˆê@ˆä“c’q@aŒû—S•ã@‘댫ˆê˜Y@‚‹´‹B
‹ãB‹~‹}ˆãŠwŽGŽ 6(1): 20-23; 2006

2005”N

Large-Scale Cohort Study on the Relationship Between Serum Lipid Concentrations and Risk of Cerebrovascular Disease Under Low-Dose Simvastatin in Japanese Patients with Hypercholesterolemia. Sub-Analysis of the Japan Lipid Intervention Trial (J-LIT)

The J-LIT Study Group
Circ J 69: 1016-1021, 2005

HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients

Takahashi T, Ishii N, Itai K, Goto R, Higashi K, Kobori S
J Atheroscler Thromb 12: 149-153, 2005

Critical Pathways for Emergency Disease Available in the Emergency and Critical Care Center

Takahashi T, Oiso H Harada M, Hashimoto S, Yoshioka A, Kobori S, Miyazaki H
JJAAM 16: 103-108, 2005

Autopsy and pathological diagnosis of cardiopulmonary arrest on arrival cases in which the cause of death is undetermined

Takahashi T, Oiso H, Miyauchi D, Harada M, Hashimoto S, Yoshioka A, Kobori S, Miyazaki H
Jpn J Reanimatology 24: 32-34, 2005

An Autopsy Study of 36 Cases of Cardiopulmonary Arrest on Arrival with Acute Myocardial Infarction

Takahashi T, Miyauchi D, Oiso H, Harada M, Hashimoto S, Yoshioka A, Kobori S
JJAAM 16: 9-12, 2005

2004”N

ƒZƒŒƒEƒX‹Û‚É‚æ‚éW’cH’†“ʼn€Ž™‚̎󂯓ü‚ê‚ÌŒoŒ±

éáŽq ‚“‡ƒVƒmƒu ‚‹´‹B
“ú—Õ‹~ˆãŽ 7: 55-59, 2004

2003”N

“œ”A•a‚ւ̃NƒŠƒeƒBƒJƒ‹ƒpƒX‚̉ž—p

¬–xËŽO@‚‹´‹B@“Œ‹Pˆê˜N@傌´Œ«Ži@‹{‘ºM”Ž@ŽR“c˜a”́@Œã“¡‰ÃŽ÷@‹g¬Œ³F@•½¼^—S@“Œ“°—´•½@‹{è‹v‹`
“úˆãƒ}ƒlƒWƒƒ“ƒg‰ïŽ 4(2): 292-296, 2003

–å–¬“àƒKƒXŒŒÇ‚ð’悵Ž€–S‚µ‚½“œ”A•a«ƒPƒgƒAƒVƒh[ƒVƒX‚Ì‚P—á

–ì–žˆè@‚‹´‹B@‹g‰ª–¾Žq@¬–xËŽO@‹{è‹v‹`
‘h¶ 22: 133-136, 2003

Fatal enterohemorrhagic Escherichia coli O25 infection associated with rapidly progressive hyperkalemia and hemolytic uremic syndrome. Case Report

Takahashi T, Nomitsu I, Yoshioka A, Kobori S, Miyazaki H
Jpn J Reanimatology 22: 129-132, 2003

ŠÌd•Ï‚𔺂¤“œ”A•aŠ³ŽÒ‚É‚¨‚¯‚鎡—Â̒ˆÓ“_

–î–ì”ü—R‹I@‚‹´‹B@“‡“c’B–ç@“Œ‹Pˆê˜N@¬–xËŽO
‘ŒF–{ˆãŽ 3(1): 97-99, 2003

Sustained Reduction of Serum Cholesterol in Low-Dose &-Year Simvastatin Treatment With Minimum Side Effects in 51,321 Japanese Hypercholesterolemic Patients-Implication of the J-LIT Study, a Large Scale Nationwide Cohort Study-

The J-LIT Study Group
Circ J 67(4): 287-294, 2003

‚Ž‰ŒŒÇE‚”AŽ_ŒŒÇ‡•¹—á‚ɑ΂·‚éƒtƒFƒmƒtƒBƒuƒ‰[ƒg‚ÌŽg—pŒoŒ±

¬–xËŽO@–ì–žˆè@‚‹´‹B
Progress in Medicine 23: 277-279, 2003

2002”N

Percutaneous Transluminal Thrombotransfer Therapy for the Proximal ICA Obstruction due to Large Emboli; Report of Two Cases

Takahashi T, Ishizaki M, Kawano H, Ikeda T, Matsumoto T, Yoshioka A, Ikei S
JJAAM 13: 680-685, 2002

Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy

Takahashi T, Yano M, Minami J, Haraguchi T, Koga N, Higashi K, Kobori S
Diab Res and Clin Pract 58: 123-129, 2002

Large Scale Cohort Study of Relationship Between Serum Cholesterol Concentraation and Coronary Events With Low-Dose Sinvastatin Therapy in Japanese Patients With Hypercholesterolemia and Coronary Heart Disease-Secondary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT)-

The J-LIT Study Group
Circ J 66(12): 1096-1100, 2002

Large Scale Cohort Study of Relationship Between Serum Cholesterol Concentraation and Coronary Events With Low-Dose Sinvastatin Therapy in Japanese Patients With Hypercholesterolemia and Coronary Heart Disease-Primary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT)-

The J-LIT Study Group
Circ J 66(12): 1087-1095, 2002

ŒŒ“œƒRƒ“ƒgƒ[ƒ‹ƒNƒŠƒeƒBƒJƒ‹ƒpƒX‚É‚æ‚éˆã—Â̎¿‚ÌŒüã

¬–xËŽO@–î–ì”ü—R‹I@–ì–žˆè@‚‹´‹B@“Œ‹Pˆê˜N@‹{è‹v‹`
“úˆãƒ}ƒlƒWƒƒ“ƒg‰ïŽ 3(2): 262-266, 2002

ŒF–{Žs‚É‚¨‚¯‚é’†“Å”À‘—Ç—á‚Ì•ªÍ

¼‰ª˜a’j@Œã“¡’BL@“¹‰zŒ«@‚‹´‹B
‘ŒF–{ˆãŽ 2(1): 62-66, 2002

‘—§ŒF–{•a‰@“œ”A•aƒZƒ“ƒ^[‚É‚¨‚¯‚é”DP“œ”A•a‚ÌŽ¡—ÃŒoŒ±

“Œ‹Pˆê˜N@¬–xËŽO@‚‹´‹B@“‡“c’B–ç@¼ˆä˜a•v@—MŒ´®Ž÷@ˆÉˆäçŒi
‘ŒF–{ˆãŽ 2(1): 46-50, 2002

Effects of bezafibrate on serum lipoproteins including apolipoprotein A-I-containing lipoproteins in type III hyperlipoproteinemia with apolipoprotein E phenotype E2/E2

Kobori S, Takahashi T, Sasahara T, Sakai M, Matsumura T
Med J Kumamoto Natl Hosp 2(1): 32-40, 2002

‹~‹}ˆã—ÃZƒ“ƒ^[‚Å‚ÌŒo‰ßŠÏŽ@“ü‰@ƒNƒŠƒeƒBƒJƒ‹ƒpƒX‚̍쐬‚Æ“±“ü‚ÌŒø‰Ê

‰Í“‡‹žŽq@–î–ì”ü—R‹I@•Ÿ•yNÉ@¼–{•Žm@–L“c–ƒ—Žq@‹g‰ª–¾Žq@‚‹´‹B@’rˆäãà
“úˆãƒ}ƒlƒWƒƒ“ƒg‰ïŽ 2: 347-350, 2002

2001”N

Superselective Thrombolytic Therapy for Acute Phase Atherothrombotic Brain Ischemia: Compared to Embolic Brain Ischemia

Takahashi T, Suefuji H, Tokunaga M, Kurisaki R, Toyoda M, Yoshioka A, Ikei S
JJAAM 12: 360-365, 2001

´—Áˆù—¿…‘½ˆù‚É‚æ‚鍂Z“§ˆ³«”ñƒPƒgƒ“«¨‡‚É‚æ‚è”­Œ©‚³‚ꂽŽá”N‚QŒ^“œ”A•a‚̈ê—á -‚¢‚í‚ä‚鐴—Áˆù—¿…ƒPƒg[ƒVƒX-

ŒÃ‰ê’¼Žq@‚‹´‹B@“쏇Žq@”’”ö—FG@Œ´Œû’mŽq@“Œ‹Pˆê˜N@¬–xËŽO
‘ŒF–{ˆãŽ 1(1): 66-68, 2001

‘—§ŒF–{•a‰@‚É”À“ü‚³‚ꂽŽ©ŽEŠé}Š³ŽÒ‚ÌŒŸ“¢

–{“c‘‘‰î@XŒ’‘¾@…’J‚¦‚è‚©@“n•ÓM•v@“n•ÓŒ’ŽŸ˜Y@’rˆäãà@‚‹´‹B@–؉º—Tˆê˜Y@‹g‰ª–¾Žq
‘ŒF–{ˆãŽ 1(1): 31-34, 2001

Analysis of 300 patients with cardiopulmonary arrest on arrival to the emergency department

Yoshioka A, Takahashi T, Kinoshita Y, Minami J, Kozaki Y, Honda S, Suefuji H, Murayama T, Kobori S, Ikei S
Med J Kumamoto Natl Hosp 1(1): 15-18, 2001

Increased plasma level of soluble E-selectin in acute myocardial infarction

Suefuji H, Miyagi H, Kei J, Fujimoto K, Takahashi T, Miyao Y, Sakaguchi H, Shirao T, Yoshida T, Takaji K, Yoshioka A, Minami J
Med J Kumamoto Natl Hosp 1(1): 8-14, 2001

‹}«ŠúdÇ”][Ç‚ɑ΂·‚é’´‘I‘ð“I”]ŒŒð—n‰ð—Ö@‚ÌŽŽ‚Ý

‚‹´‹B@––“¡‹v˜a@“¿‰i½@‹g‰ª–¾Žq@–{“cÈ“ñ@“쏇Žq@Kè–í”V•@–؉º—Tˆê˜Y@åUŒ³¹Žq@•½Œ´’q—Y
“ú—Õ‹~ˆãŽ 4: 4-7, 2001

2000”N

Ÿ÷–Œ‰ºŽq‹{‹ØŽîŒs”P“]‚É‚æ‚é‹}«• Ç‚Ì‚P—á

‹g‰ª–¾Žq@‚‹´‹B@–؉º—Tˆê˜Y@’rˆäãà@•Ÿ¼”V“ց@ŽOXŠ°K@“¿‰i’B–ç
“ú‹~‹}ˆã‰ïŽ 11: 701-704, 2000

–{‘Ԑ«‚ŒŒˆ³Ç‚ð‡•¹‚µ‚½IIbŒ^‚Ž‰ŒŒÇ‚ɃtƒFƒmƒtƒBƒuƒ‰[ƒg‚ª‘tŒø‚µ‚½1—á

¬–xËŽO@ŒÃ‰ê’¼Žq@“쏇Žq@‚‹´‹B
V–ò‚ƗՏ° 49: 78-80, 2000

S”x’âŽ~‘h¶Œã‚É”­¶‚µ‚½‰ES–[“àŒŒðÇ‚Ì1—á

‚‹´‹B@Œ´Œû’mŽq@––“¡‹v˜a@‹{”ö—YŽ¡@“¡–{˜a‹P@‹{éG¶@‹{è‹v‹`@²“¡G”V
‘h¶ 19: 156-159, 2000

Ò‘“®Ã–¬ŠïŒ`”j—ô‚É‚æ‚铪ŠW“àƒNƒ‚–Œ‰ºoŒŒ‚Ì1—á

‚‹´‹B@à_“cˆê–ç@–؉º—Tˆê˜Y@‹g‰ª–¾Žq@–k–ìˆè•v
“ú‹~‹}ˆã‰ïŽ 11: 186-190, 2000

Design and Baseline Characteristics of a Cohort Study in Lapanese Patients with Hypercholesterolemia: The Japan Lipid Intervention Trial (J-LIT)

The J-LIT Study Group
Current Theraputic Research 61(4): 219-243, 2000

TOP‚Ö